journal article·2019-01-14

Protective Role of Decellularized Human Amniotic Membrane from Oxidative Stress-Induced Damage on Retinal Pigment Epithelial Cells

Lekshmi Krishna, Kamesh Dhamodaran, Murali Subramani, Murugeswari Ponnulagu, Nallathambi Jeyabalan, Sai Rama Krishna Meka, Chaitra Jayadev, Rohit Shetty, Kaushik Chatterjee, Samanta Sekhar Khora, Debashish Das

Publisher page

Abstract

Oxidative stress is an important cause for several retinal aging diseases. Cell therapy using a decellularized human amniotic membrane (dHAM) as a tissue scaffold for retinal pigment epithelial cells has a potential therapeutic role under such pathological conditions. This is attributed by the anti-inflammatory, antimicrobial, low-immunogenicity aspects of dHAM, apart from harboring a drug reservoir potential. The underlying mechanisms for maintaining the physiological properties of transplanted cells and their survival in a diseased milieu using dHAM has remained unexplored/unanswered. Hence, we investigated the potential role of dHAM in preserving the cellular functions of retinal pigment epithelium in an oxidative stress environment. Adult human retinal pigment epithelial (ARPE-19) cells were cultured on dHAM or tissue culture dishes under hyperoxia. Gene expression, immunofluorescence staining, enzyme-linked immunosorbent assay (ELISA), and scanning electron microscopy (SEM) were performed to assess the levels of reactive oxygen species, proliferation, apoptosis, epithelial-mesenchymal transition, phagocytosis, and secretion of vascular endothelial factors. These results indicate reduced epithelial-mesenchymal transition, generation of reactive oxygen species (p ≤ 0.0001), and apoptosis (p ≤ 0.05) in cells cultured on dHAM, compared to those on tissue culture dishes under oxidative stress conditions. Concomitantly, the secretion of the vascular endothelial growth factor was significantly reduced (p ≤ 0.01) on dHAM. Phagocytic activity was significantly higher (p ≤ 0.001) in cells cultured on dHAM and were comparable to those cells cultured on tissue culture dishes. SEM images showed a clustered growth pattern on dHAM compared to an elongated morphology when cultured on tissue culture dishes under oxidative stress conditions. These findings demonstrate the utility of dHAM as a scaffold for growing retinal epithelial cells and to maintain their physiological properties in an oxidative stress condition with a potential to develop regenerative medicine strategies to treat degenerative eye diseases.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Corneal Surgery and Treatments · Tissue Engineering and Regenerative Medicine · Retinal and Macular Surgery

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Stem Cell Research Lab, GROW Laboratories, Narayana Nethralaya Foundation, 258/A, Bommasandra Industrial Area, Bangalore, Karnataka, India

School of Bioscience and Technology, VIT University, Vellore, Tamil Nadu, India

Grow Laboratories, Narayana Nethralaya Foundation, 258/A, Bommasandra Industrial Area, Bangalore, Karnataka, India

Department of Materials Engineering, Indian Institute of Science, Bangalore, Karnataka, India

Department of Vitreo-retinal Services, Narayana Nethralaya Eye Institute, 258/A, Bommasandra Industrial Area, Bangalore, Karnataka, India

Department of Cornea and Refractive Surgery, Narayana Nethralaya Eye Institute, 258/A, Bommasandra Industrial Area, Bangalore, Karnataka, India

Funding

Department of Science and Technology, Ministry of Science and Technology · Narayana Nethralaya Foundation

References (77)

Show source-provided references
1. 10.1016/j.mam.2012.03.00910.1016/j.mam.2012.03.009 ↗
2. 10.1155/2017/920848910.1155/2017/9208489 ↗
3. 10.1016/j.cub.2014.03.03410.1016/j.cub.2014.03.034 ↗
4. 10.1034/j.1600-0420.2003.00076.x10.1034/j.1600-0420.2003.00076.x ↗
5. 10.1111/rda.1263310.1111/rda.12633 ↗
6. 10.1167/iovs.15-1833010.1167/iovs.15-18330 ↗
7. 10.1016/j.cyto.2017.02.01310.1016/j.cyto.2017.02.013 ↗
8. 10.1038/srep1638610.1038/srep16386 ↗
9. 10.1111/j.1755-3768.2012.02426.x10.1111/j.1755-3768.2012.02426.x ↗
10. 10.1038/s41598-017-12496-z10.1038/s41598-017-12496-z ↗
11. 10.1007/s10528-010-9409-110.1007/s10528-010-9409-1 ↗
12. 10.4103/0301-4738.1617410.4103/0301-4738.16174 ↗
13. 10.1155/2012/71696810.1155/2012/716968 ↗
14. 10.1007/s00417-005-0061-010.1007/s00417-005-0061-0 ↗
15. 10.1167/iovs.05-156510.1167/iovs.05-1565 ↗
16. Lopez R. · Invest. Ophthalmol. Vis. Sci. · 1989 · 30 · 586
17. 10.1016/S0014-4835(05)80168-X10.1016/S0014-4835(05)80168-X ↗
18. 10.1006/exnr.1998.684910.1006/exnr.1998.6849 ↗
19. 10.1167/iovs.05-027910.1167/iovs.05-0279 ↗
20. 10.1016/j.jcyt.2016.01.00310.1016/j.jcyt.2016.01.003 ↗
21. 10.18632/aging.10051610.18632/aging.100516 ↗
22. 10.1016/j.bbamcr.2016.09.01210.1016/j.bbamcr.2016.09.012 ↗
23. 10.1007/s00018-002-8410-110.1007/s00018-002-8410-1 ↗
24. Middleton C. A. · J. Cell Sci. · 1988 · 91 · 33710.1242/jcs.91.3.337 ↗
25. 10.1111/j.1600-0463.2007.apm_514.x10.1111/j.1600-0463.2007.apm_514.x ↗
26. 10.1097/WOX.0b013e318243961310.1097/WOX.0b013e3182439613 ↗
27. 10.1155/2014/57465910.1155/2014/574659 ↗
28. 10.1016/j.jcjo.2014.07.00510.1016/j.jcjo.2014.07.005 ↗
29. 10.1016/j.cell.2014.12.01910.1016/j.cell.2014.12.019 ↗
30. Honda S. · Mol. Vis. · 2001 · 7 · 63
31. 10.1002/(SICI)1097-4652(200003)182:3<311::AID-JCP1>3.0.CO;2-910.1002/(SICI)1097-4652(200003)182:3<311::AID-JCP1>3.0.CO;2-9 ↗
32. 10.17925/USOR.2007.03.00.3510.17925/USOR.2007.03.00.35 ↗
33. 10.1073/pnas.93.8.350910.1073/pnas.93.8.3509 ↗
34. 10.1073/pnas.97.2.52910.1073/pnas.97.2.529 ↗
35. 10.1093/emboj/18.9.233010.1093/emboj/18.9.2330 ↗
36. 10.1083/jcb.139.5.128110.1083/jcb.139.5.1281 ↗
37. 10.1038/nrm149610.1038/nrm1496 ↗
38. 10.1038/srep4373610.1038/srep43736 ↗
39. 10.1371/journal.pone.011995410.1371/journal.pone.0119954 ↗
40. 10.1172/JCI3910410.1172/JCI39104 ↗
41. 10.1111/j.1432-0436.2006.00133.x10.1111/j.1432-0436.2006.00133.x ↗
42. 10.1038/nrm375810.1038/nrm3758 ↗
43. Ohno-Matsui K. · Mol. Vis · 2005 · 11 · 1
44. Orzalesi N. · Invest. Ophthalmol. Vis. Sci. · 1982 · 23 · 689
45. 10.1111/j.1699-0463.1996.tb00716.x10.1111/j.1699-0463.1996.tb00716.x ↗
46. 10.22203/eCM.v015a0710.22203/eCM.v015a07 ↗
47. 10.4103/jispcd.JISPCD_359_1610.4103/jispcd.JISPCD_359_16 ↗
48. 10.1166/jbt.2016.148010.1166/jbt.2016.1480 ↗
49. 10.530/ijao.500030710.530/ijao.5000307 ↗
50. 10.1080/21691401.2018.145873010.1080/21691401.2018.1458730 ↗
51. 10.1177/204173141772084110.1177/2041731417720841 ↗
52. 10.1097/01.ico.0000151501.80952.c510.1097/01.ico.0000151501.80952.c5 ↗
53. 10.1097/00003226-200005000-0001810.1097/00003226-200005000-00018 ↗
54. 10.4103/0301-4738.3303610.4103/0301-4738.33036 ↗
55. 10.1076/0271-3683(200003)2031-9FT17310.1076/0271-3683(200003)2031-9FT173 ↗
56. 10.1136/bjo.86.2.15910.1136/bjo.86.2.159 ↗
57. 10.1002/jcp.104073020510.1002/jcp.1040730205 ↗
58. 10.1167/iovs.12-1006810.1167/iovs.12-10068 ↗
59. 10.1111/j.1600-0781.2010.00551.x10.1111/j.1600-0781.2010.00551.x ↗
60. 10.1177/153537021558753010.1177/1535370215587530 ↗
61. 10.1007/BF0004769210.1007/BF00047692 ↗
62. 10.1001/archophthalmol.2010.22210.1001/archophthalmol.2010.222 ↗
63. Jin M. · Invest. Ophthalmol. Visual Sci. · 2000 · 41 · 4324
64. 10.1038/sj.onc.120540710.1038/sj.onc.1205407 ↗
65. 10.1016/0922-3371(89)90077-410.1016/0922-3371(89)90077-4 ↗
66. 10.22376/ijpbs.2017.8.1.b316-32310.22376/ijpbs.2017.8.1.b316-323 ↗
67. 10.1016/j.bbrc.2007.11.15910.1016/j.bbrc.2007.11.159 ↗
68. 10.1155/2017/396217310.1155/2017/3962173 ↗
69. 10.1038/msb.2013.4710.1038/msb.2013.47 ↗
70. 10.3892/ijmm.2015.211610.3892/ijmm.2015.2116 ↗
71. 10.1016/j.exer.2014.01.01010.1016/j.exer.2014.01.010 ↗
72. 10.1016/j.stemcr.2018.01.01710.1016/j.stemcr.2018.01.017 ↗
73. 10.3980/j.issn.2222-3959.2015.01.0510.3980/j.issn.2222-3959.2015.01.05 ↗
74. 10.4172/2155-9570.100053710.4172/2155-9570.1000537 ↗
75. 10.4172/2155-952X.100027210.4172/2155-952X.1000272 ↗
76. 10.3760/cma.j.issn.2095-0160.2013.05.00510.3760/cma.j.issn.2095-0160.2013.05.005 ↗
77. Resch M. D. · 2015 · 17710.1007/978-94-017-9975-1_11 ↗